Rapture Therapeutics Inc. (RAPT): Surprised that no gap fill occurred prio...

Featured News Placeholder

American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility...

USOTC:ERBB

Featured News Placeholder

With Prime Featured, display your headline and ticker symbol on the pages where our users live.

Rapture Therapeutics Inc. (RAPT)

Reply Private New

Prev Next

Send PM

Followers	41
Posts	5640
Boards Moderated	9
Alias Born	04/12/2021

FREE
RAPT REPORT

Re: None

Tuesday, 09/06/2022 2:54:47 AM

Tuesday, September 06, 2022 2:54:47 AM

Surprised that no gap fill occurred prior to results expected near September 12, showing major strength buoyed by estimates of 50.00:

“8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced it has initiated its 16-week randomized, double-blind, placebo-controlled Phase 2b clinical trial to further evaluate the efficacy and safety of RPT193 as monotherapy in patients with moderate-to-severe atopic dermatitis (AD).”

my posts are always theory and not financial advice

Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RAPT News

RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference • GlobeNewswire Inc. • 02/07/2023 01:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:24:41 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:22:23 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:13:38 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:09:19 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/26/2023 07:30:29 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 11:34:11 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/17/2023 09:11:47 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 01:04:00 PM
RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 09:03:57 PM
SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 12/12/2022 11:35:26 AM
RAPT Therapeutics Presents Update from its Phase 1/2 Clinical Trial for FLX475 as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Cancer • GlobeNewswire Inc. • 12/08/2022 11:30:00 AM
RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress • GlobeNewswire Inc. • 12/01/2022 12:05:22 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 11/18/2022 09:53:04 PM
RAPT Therapeutics Tanks on $75M Public Offering • TipRanks • 11/18/2022 11:39:00 AM
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 11/18/2022 02:38:04 AM
RAPT Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 11/17/2022 09:24:51 PM
SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 11/14/2022 03:55:48 AM
Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:22:24 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:13:00 PM
RAPT Therapeutics Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/10/2022 01:00:00 PM
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2022 01:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/03/2022 10:45:29 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/04/2022 04:48:02 PM

More RAPT News

InvestorsHub NewsWire

FEATURED American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7, • Feb 7, 2023 9:17 AM

FEATURED Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone • Feb 7, 2023 7:00 AM

Chairman & CEO Joshua Sodaitis Announces Annual Letter to Shareholders • PTOP • Feb 7, 2023 10:00 AM

American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow • ERBB • Feb 7, 2023 9:17 AM

Good Gaming Inc. To Launch Its First Extreme Game Mob Wars For Advanced Players As Minecraft and Roblox Continue To Experience Rapid Growth • GMER • Feb 7, 2023 8:30 AM

B2Digital's B2 Fighting Series Kicks Off 2023 with New Single-Event Company Record at B2FS 178 • BTDG • Feb 7, 2023 8:30 AM

Start posting your company's news

Only $200 per official company press release!